India's Covid-19 Fatality Rate Stands At 2.82%, Lowest In World: Health Ministry

As per the data provided by the Centre, the recovery rate on May 18 stood at 38.29 per cent, on May 3, it was 26.59 per cent and on April 15, it was 11.42 per cent.

Medics and hospital staff applaud as patients who recovered from COVID-19 prepare to leave Krishna Hospital, during the ongoing COVID-19 nationwide lockdown. (Image: PTI)

New Delhi: With more than 8,100 new Coronavirus cases in last 24 hours, India's tally has pushed to 1,98,706 on Tuesday, making the country approaching towards the 2 lakh mark soon. In term of deaths, India reported as many as 204 new fatalities in a single day, taking the toll to 5,598. However, the Union Health Ministry has asserted that the recovery rate is constantly improving while the fatality rate is declining. In a press conference on Tuesday afternoon, Joint Secretary Lav Agrawal said that India's fatality rate is one of the lowest in the world. "A total of 95,552 patients have recovered from the contagious disease. The recovery rate of corona patients in the nation is continuously improving and stands at 48.07 per cent now, up from 11.42 per cent on April 15," Agrawal said.

Our #COVID19 fatality rate of 2.82% is amongst the lowest in the world, compared to a global fatality rate of 6.13%. We have been able to achieve this due to timely identification of cases and proper clinical management.

- @MoHFW_INDIA pic.twitter.com/jSm74CnD0w — PIB India #StayHome #StaySafe (@PIB_India) June 2, 2020

As per the data provided by the Centre, the recovery rate on May 18 stood at 38.29 per cent, on May 3, it was 26.59 per cent and on April 15, it was 11.42 per cent. Briefing over the fatality situation in the country, the official assured that death rate in India is declining as fatality rate per lakh population (of 0.41) is amongst the lowest in the world, while there are countries with a figure as high as 62 and 82 "Our COVID19 fatality rate of 2.82% is amongst the lowest in the world, compared to a global fatality rate of 6.13%. We have been able to achieve this due to timely identification of cases and proper clinical management," government said.

73% of #COVID19 deaths in the nation have been of people with co-morbidities such as diabetes, hypertension, heart and respiratory diseases - @MoHFW_INDIA pic.twitter.com/vYgFDUpTyl

— PIB India #StayHome #StaySafe (@PIB_India) June 2, 2020

Further in the conference, JS Lav Agrawal requested citizens  to support high risk group population and to help control the spread of Corona infection. For the same, he said it is important to be aware of the evolving situation, keep taking preventive efforts and adopt timely advice and treatment for coronavirus. Meanwhile, the Health Ministry also said on Tuesday that it has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use in treating Covid-19 patients. Remdesivir is the first drug to show improvement in Covid-19 patients in formal clinical trials. “The DCGI gave an emergency use permission for remdesivir... and this was based on evidence that was provided by the company to support its use against covid-19," Agarwal said while addressing a press conference earlier in the day. It was granted emergency use authorization by the United States Food and Drug Administration last month and has received approval by Japanese health regulators.